What is the coverage and dosing regimen for Ancef (Cefazolin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ancef (Cefazolin) Coverage and Dosing

Ancef (cefazolin) is a first-generation cephalosporin that provides excellent coverage against methicillin-susceptible Staphylococcus aureus (MSSA), streptococci including Streptococcus pneumoniae, and many gram-negative organisms including Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis, but lacks activity against MRSA, enterococci, and most anaerobes. 1, 2

Antimicrobial Spectrum

Gram-Positive Coverage

  • Highly effective against MSSA - this is a primary indication for cefazolin 1, 3
  • Excellent activity against Streptococcus pneumoniae and Group A/B streptococci 1, 2
  • Does NOT cover MRSA - alternative agents like vancomycin or linezolid must be used if MRSA is suspected 3
  • Does NOT cover enterococci 2

Gram-Negative Coverage

  • Good activity against E. coli and Klebsiella species (4-8 fold more active than other first-generation cephalosporins) 4, 5
  • Covers Proteus mirabilis effectively 5, 6
  • Limited activity against indole-positive Proteus species 5
  • Does NOT cover Pseudomonas aeruginosa or other non-fermenting gram-negatives 2

Anaerobic Coverage

  • Minimal to no anaerobic coverage - not appropriate for infections requiring anaerobic coverage 2

Standard Dosing Regimens

Adult Dosing for Infections

For MSSA skin and soft tissue infections: 1 gram IV every 8 hours 1, 3

For moderate to severe infections: 500 mg to 1 gram IV every 6-8 hours 2

For severe, life-threatening infections (endocarditis, septicemia): 1-1.5 grams IV every 6 hours 2

For mastitis: 1 gram IV every 8 hours for 7-10 days (increase to 2 grams every 8 hours for severe infections) 3

For mild infections from susceptible gram-positive cocci: 250-500 mg IV every 8 hours 2

For uncomplicated UTI: 1 gram IV every 12 hours 2

For pneumococcal pneumonia: 500 mg IV every 12 hours 2

Surgical Prophylaxis Dosing

Standard surgical prophylaxis: 2 grams IV administered 30-60 minutes prior to incision, with redosing of 1 gram if procedure duration exceeds 4 hours 7

For cardiac surgery: 2 grams IV plus 1 gram in cardiopulmonary bypass priming solution, with redosing of 1 gram at the 4th hour intraoperatively 7

For neurosurgery/spine surgery with implants: 2 grams IV as single dose, with redosing of 1 gram if duration exceeds 4 hours 7

For urologic procedures: 1 gram IV every 8 hours 7

Postoperative prophylaxis: 500 mg to 1 gram IV every 6-8 hours for 24 hours postoperatively (may extend to 3-5 days for high-risk procedures like open-heart surgery or prosthetic arthroplasty) 2

Pediatric Dosing

For mild to moderate infections: 25-50 mg/kg/day divided every 8 hours (or every 6 hours) 2

For severe infections: Up to 100 mg/kg/day divided every 8 hours 2

For staphylococcal infections: 33 mg/kg/dose IV every 8 hours (or 150 mg/kg/day divided every 8 hours) 1, 7, 3

For infective endocarditis: 100 mg/kg/day IV divided every 8 hours (maximum 12 grams daily) 1, 7

For CNS infections: 100 mg/kg/day divided every 8 hours to ensure adequate CNS penetration 7

For GBS prophylaxis in neonates (maternal dosing): 2 grams IV initial dose, then 1 gram IV every 8 hours until delivery 1

Safety note: Not recommended for premature infants and neonates due to lack of established safety data 2

Renal Dose Adjustments

Critical consideration: Failure to adjust dosing in renal impairment can lead to drug accumulation, neurotoxicity, and seizures 8

CrCl ≥55 mL/min or SCr ≤1.5 mg/dL: Full dose with no adjustment 2

CrCl 35-54 mL/min or SCr 1.6-3.0 mg/dL: Full dose but extend interval to at least every 8 hours 2

CrCl 11-34 mL/min or SCr 3.1-4.5 mg/dL: Give 1/2 usual dose every 12 hours (after loading dose) 2

CrCl ≤10 mL/min or SCr ≥4.6 mg/dL: Give 1/2 usual dose every 18-24 hours (after loading dose) 2

Pharmacokinetic Advantages

  • Prolonged half-life: 2 hours (versus 1.4 hours for cephaloridine), allowing for less frequent dosing 4
  • High serum levels: Achieves peak concentrations of 38.8 mcg/mL after 1 gram IM, with detectable levels at 8 hours 4, 6
  • Good tissue penetration: Effective penetration into breast tissue and other soft tissues 3, 6
  • High protein binding: 81% protein-bound, which may reduce free drug activity in serum but contributes to sustained levels 4
  • Painless IM administration: Unlike other cephalosporins, cefazolin causes minimal pain with intramuscular injection 5, 6

Critical Pitfalls and Caveats

Dosing Errors

  • Never confuse cefazolin with ertapenem - ertapenem is dosed once daily, while cefazolin requires every 6-8 hour dosing for most infections 1
  • Do not use once-daily dosing except in specific surgical prophylaxis contexts - this leads to subtherapeutic trough levels 1
  • Always adjust for renal dysfunction - a case report documented fatal seizures from excessive dosing (2 grams every 4 hours instead of every 12 hours) in a patient with renal impairment 8

Coverage Limitations

  • Failure to cover MRSA will result in treatment failure - if MRSA is suspected or confirmed, switch to vancomycin or linezolid 3
  • Inadequate for abscess without drainage - antibiotics alone will fail if surgical drainage is not performed 3
  • Not effective for anaerobic infections - add metronidazole or use alternative agents for polymicrobial infections 2

Monitoring Requirements

  • Clinical response should occur within 48-72 hours - if no improvement, obtain cultures, broaden coverage, or evaluate for complications like abscess formation 3
  • Monitor renal function especially in elderly patients, those with pre-existing CNS conditions, or baseline renal impairment, as these factors potentiate neurotoxicity risk 8

Penicillin Allergy Considerations

  • Cefazolin can be safely used in most patients with penicillin allergy, though cross-reactivity concerns have historically led to use of less effective alternatives 9
  • For severe beta-lactam allergy, use vancomycin (30 mg/kg/day in 2 divided doses) or clindamycin (600-900 mg IV every 8 hours) as alternatives 3

References

Guideline

Cefazolin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cefazolin Regimen for Mastitis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bactericidal activity and pharmacology of cefazolin.

Antimicrobial agents and chemotherapy, 1973

Research

Clinical studies of cefazolin and comparison with other cephalosporins.

Antimicrobial agents and chemotherapy, 1973

Guideline

Cefazolin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.